Therapeutic efficacy monitoring of pyronaridine-artesunate (Pyramax®) in treating uncomplicated Plasmodium falciparum malaria in Gia Lai province, Vietnam from 2022 to 2023.

Saved in:
Bibliographic Details
Title: Therapeutic efficacy monitoring of pyronaridine-artesunate (Pyramax®) in treating uncomplicated Plasmodium falciparum malaria in Gia Lai province, Vietnam from 2022 to 2023.
Authors: Van Thanh N; Department of Parasitology, Hanoi Medical University, Hanoi, Vietnam.; Department of Malariology, Vietnam People's Army Military Institute of Preventive Medicine (MIPM), Hanoi, Vietnam., Quang HH; Tropical Diseases Clinical and Treatment Research Department, Vietnam Ministry of Health Institute of Malariology, Parasitology and Entomology, Quy Nhon, (IMPE-QN), Quy Nhon, Vietnam., San NN; Department of Parasitology, Hanoi Medical University, Hanoi, Vietnam., Cuong NK; Department of Malariology, Vietnam People's Army Military Institute of Preventive Medicine (MIPM), Hanoi, Vietnam., Trinh NTM; Tropical Diseases Clinical and Treatment Research Department, Vietnam Ministry of Health Institute of Malariology, Parasitology and Entomology, Quy Nhon, (IMPE-QN), Quy Nhon, Vietnam., Van Khanh C; Tropical Diseases Clinical and Treatment Research Department, Vietnam Ministry of Health Institute of Malariology, Parasitology and Entomology, Quy Nhon, (IMPE-QN), Quy Nhon, Vietnam., Edgel KA; Science Department, U.S. Naval Medical Research Unit (NAMRU) INDO PACIFIC, Singapore, Singapore., Nguyen HC; Science Department, U.S. Naval Medical Research Unit (NAMRU) INDO PACIFIC, Singapore, Singapore., Letizia AG; Science Department, U.S. Naval Medical Research Unit (NAMRU) INDO PACIFIC, Singapore, Singapore., Birrell GW; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Martin NJ; Science Department, U.S. Naval Medical Research Unit (NAMRU) INDO PACIFIC, Singapore, Singapore., Edstein MD; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia., Chavchich M; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Oct 03; Vol. 80 (10), pp. 2630-2634.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1460-2091
DOI:10.1093/jac/dkaf234